ALA derivatives - PhotoCure

Drug Profile

ALA derivatives - PhotoCure

Alternative Names: Aminolevulinate derivatives - PhotoCure

Latest Information Update: 17 Feb 2009

Price : $50

At a glance

  • Originator PhotoCure
  • Developer Photocure
  • Class Amino acids; Keto acids; Levulinic acids; Small molecules
  • Mechanism of Action Photosensitisers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Brain cancer; Breast cancer; Colorectal cancer; Gynaecological cancer; Head and neck cancer; High-grade oesophageal dysplasia

Most Recent Events

  • 29 Apr 2005 Discontinued - Phase-I for Head and neck cancer in Norway (unspecified route)
  • 29 Apr 2005 Discontinued - Phase-I for High-grade oesophageal dysplasia in Norway (unspecified route)
  • 15 Apr 2003 Phase-I clinical trials in Gynaecological cancer in Germany (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top